INS and diabetes mellitus: This concentration appears far below the therapeutic dose for the systemic activation of peroxisome proliferator–activated receptor γ (PPAR-γ) commonly used for insulin sensitization for diabetes treatment (i.e. 3–10 mg/kg/day in rats)28.